Rapilin® (Repaglinide Tablets) – 0.5 mg | 1 mg | 2 mg

Rapilin® (Repaglinide Tablets) is an oral antidiabetic medicine from the meglitinide class, indicated for the management of type 2 diabetes mellitus, particularly for controlling post-meal blood glucose spikes. It works by stimulating rapid insulin release from the pancreas in response to meals.

Rapilin is typically taken before meals and may be prescribed alone or in combination with other antidiabetic agents such as metformin when diet and exercise alone are insufficient. Its short duration of action makes it suitable for flexible meal schedules.

Available strengths include 0.5 mg, 1 mg, and 2 mg, allowing individualized dose titration based on glycemic response.

Medicina Overseas supplies Rapilin® tablets for global markets, supporting pharmacies, hospitals, distributors, and importers with export-ready packaging and documentation. Bulk orders and long-term supply partnerships are available on enquiry.

⚠️ Prescription medicine. Use only under medical supervision.

✅ KEY USES (OPTIONAL – HELPS CONVERSION)

• Control of post-prandial blood glucose

• Type 2 diabetes management

• Flexible, meal-time dosing

• Can be combined with metformin